Allogene Therapeutics (ALLO) stock valuation

$0.63 Nov 20, 2026 · market cap $138M

Latest briefing7/121 investors
i

Allogene Therapeutics trades at $0.63. We don't have a valuation for it yet.

7 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate ALLOCreate your account →

Full open-source research report for ALLO on DeepValues Research (CC BY 4.0)